MedTrace Logo

Study of Metabolic Syndrome Use Omega-3 Fatty Acids and Low Fat Meal

NCT01768169 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2013-01-15

No results posted yet for this study

Summary

Increased understanding of the impact of long chain omega-3 PUFAs in combination with a low fat plant-based diet will contribute to decelerating further escalation of the "epidemics" of obesity, the (pre)metabolic syndrome, and T2DM in Taiwan.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

fish oil capsule

500 mg of natural fish oil, made up of 30% omega-3 PUFA (EPA:DHA = 3:2)

Sponsors & Collaborators

  • Taipei Medical University Hospital

    lead OTHER

Principal Investigators

  • Shih-Yi Huang, Ph.D · Taipei Medical University

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-03-31
Completion
2013-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01768169 on ClinicalTrials.gov